Search Results

There are 17423 results for: content related to: A systematic review of validated methods for identifying erythema multiforme major/minor/not otherwise specified, Stevens–Johnson Syndrome, or toxic epidermal necrolysis using administrative and claims data

  1. Epidemiology of Ophthalmologic Disease Associated with Erythema Multiforme, Stevens-Johnson Syndrome, and Toxic Epidermal Necrolysis in Hospitalized Children in the United States

    Pediatric Dermatology

    Volume 31, Issue 2, March/April 2014, Pages: 163–168, Jacqueline F. Moreau, Robert S. Watson, Mary E. Hartman, Walter T. Linde-Zwirble and Laura K. Ferris

    Version of Record online : 16 MAY 2013, DOI: 10.1111/pde.12158

  2. Identification of Stevens–Johnson syndrome and toxic epidermal necrolysis in electronic health record databases

    Pharmacoepidemiology and Drug Safety

    Volume 24, Issue 7, July 2015, Pages: 684–692, Robert L. Davis, Mia A. Gallagher, Maryam M. Asgari, Melody J. Eide, David J. Margolis, Eric Macy, James K. Burmester, Nandini Selvam, Joseph A. Boscarino, Lee F. Cromwell, Heather S. Feigelson, Jennifer L. Kuntz, Pamala A. Pawloski, Robert B. Penfold, Marsha A. Raebel, Gayathri Sridhar, Ann Wu, Lois A. La Grenade, Michael A. Pacanowski and Simone P. Pinheiro

    Version of Record online : 24 APR 2015, DOI: 10.1002/pds.3778

  3. Stevens–Johnson syndrome and toxic epidermal necrolysis in patients with lupus erythematosus: a descriptive study of 17 cases from a national registry and review of the literature

    British Journal of Dermatology

    Volume 166, Issue 3, March 2012, Pages: 575–600, M. Ziemer, S.H. Kardaun, Y. Liss and M. Mockenhaupt

    Version of Record online : 22 FEB 2012, DOI: 10.1111/j.1365-2133.2011.10705.x

  4. Erythema multiforme, Stevens–Johnson syndrome and toxic epidermal necrolysis: a comparative review

    Veterinary Dermatology

    Volume 25, Issue 5, October 2014, Pages: 406–e64, Julie A. Yager

    Version of Record online : 3 JUL 2014, DOI: 10.1111/vde.12142

  5. Drug-induced Stevens–Johnson syndrome: case series from tertiary care centre in Gujarat

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 4, April 2012, Pages: 384–395, Damodar Bang, Tapan Shah, Divyesh Thakker, Yogesh Shah and Amit D. Raval

    Version of Record online : 28 FEB 2012, DOI: 10.1002/pds.3212

  6. Expression of cytokines and chemokine receptors in the cutaneous lesions of erythema multiforme and Stevens–Johnson syndrome/toxic epidermal necrolysis

    British Journal of Dermatology

    Volume 155, Issue 4, October 2006, Pages: 722–728, M. Caproni, D. Torchia, E. Schincaglia, W. Volpi, A. Frezzolini, D. Schena, A. Marzano, P. Quaglino, C. De Simone, A. Parodi, E. Barletta and P. Fabbri

    Version of Record online : 28 JUN 2006, DOI: 10.1111/j.1365-2133.2006.07398.x

  7. Erythema multiforme, Stevens–Johnson syndrome and toxic epidermal necrolysis: Frozen-section diagnosis

    The Journal of Dermatology

    Volume 37, Issue 5, May 2010, Pages: 407–412, Hiroomi HOSAKA, Shinpei OHTOSHI, Tokio NAKADA and Masafumi IIJIMA

    Version of Record online : 26 FEB 2010, DOI: 10.1111/j.1346-8138.2009.00746.x

  8. The CD40/CD40 ligand system is expressed in the cutaneous lesions of erythema multiforme and Stevens–Johnson syndrome/toxic epidermal necrolysis spectrum

    British Journal of Dermatology

    Volume 154, Issue 2, February 2006, Pages: 319–324, M. Caproni, D. Torchia, E. Schincaglia, W. Volpi, A. Frezzolini, D. Schena, A. Marzano, P. Quaglino, C. De Simone, A. Parodi, E. Barletta and P. Fabbri

    Version of Record online : 18 NOV 2005, DOI: 10.1111/j.1365-2133.2005.07023.x

  9. Using a claims database to investigate drug-induced Stevens-Johnson syndrome

    Statistics in Medicine

    Volume 10, Issue 4, April 1991, Pages: 565–576, Brian L. Strom, Jeffrey L. Carson, Allan C. Halpern, Rita Schinnar, Ellen Sim Snyder, Paul D. Stolley, Michele Shaw, Hugh H. Tilson, Michael Joseph, Wanju S. Dai, Diane Chen, Robert S. Stern, Ulf Bergman and Frank Lundin

    Version of Record online : 12 OCT 2006, DOI: 10.1002/sim.4780100408

  10. Mycoplasma pneumoniae–Associated Mucocutaneous Disease in Children: Dilemmas in Classification

    Pediatric Dermatology

    Volume 31, Issue 6, November/December 2014, Pages: 670–675, Brea Prindaville, Brandon D. Newell, Amy J. Nopper and Kimberly A. Horii

    Version of Record online : 25 NOV 2014, DOI: 10.1111/pde.12482

  11. You have free access to this content
    Severe Cutaneous Reactions Requiring Hospitalization in Allopurinol Initiators: A Population-Based Cohort Study

    Arthritis Care & Research

    Volume 65, Issue 4, April 2013, Pages: 578–584, Seoyoung C. Kim, Craig Newcomb, David Margolis, Jason Roy and Sean Hennessy

    Version of Record online : 28 MAR 2013, DOI: 10.1002/acr.21817

  12. Utilization of hospital and outpatient care for adverse cutaneous reactions to medications

    Pharmacoepidemiology and Drug Safety

    Volume 14, Issue 10, October 2005, Pages: 677–684, Robert S. Stern

    Version of Record online : 11 JAN 2005, DOI: 10.1002/pds.1065

  13. Validation of Stevens–Johnson syndrome or toxic epidermal necrolysis diagnoses in the Clinical Practice Research Datalink

    Pharmacoepidemiology and Drug Safety

    Noel Frey, Andreas Bircher, Michael Bodmer, Susan S. Jick, Christoph R. Meier and Julia Spoendlin

    Version of Record online : 20 NOV 2016, DOI: 10.1002/pds.4124

  14. Erythema multiforme, Stevens–Johnson syndrome and toxic epidermal necrolysis in northeastern Malaysia

    International Journal of Dermatology

    Volume 37, Issue 7, July 1998, Pages: 520–523, M. D. Kamaliah, . Drcog, D. Zainal, . Mbbs, N. Mokhtar and N. Nazmi

    Version of Record online : 5 JAN 2002, DOI: 10.1046/j.1365-4362.1998.00490.x

  15. Risk estimates for drugs suspected of being associated with Stevens-Johnson syndrome and toxic epidermal necrolysis: a case-control study

    Internal Medicine Journal

    Volume 35, Issue 3, March 2005, Pages: 188–190, M.-S. Lin, Y.-S. Dai, R.-F. Pwu, Y.-H. Chen and N.-C. Chang

    Version of Record online : 25 FEB 2005, DOI: 10.1111/j.1445-5994.2005.00790.x

  16. You have free access to this content
    Severe drug-induced skin reactions: clinical features, diagnosis, etiology, and therapy

    JDDG: Journal der Deutschen Dermatologischen Gesellschaft

    Volume 13, Issue 7, July 2015, Pages: 625–643, Maren Paulmann and Maja Mockenhaupt

    Version of Record online : 25 JUN 2015, DOI: 10.1111/ddg.12747

  17. Abstracts of the 24th International Conference on Pharmacoepidemiology & Therapeutic Risk Management

    Pharmacoepidemiology and Drug Safety

    Volume 17, Issue S1, August 2008, Pages: S1–S294,

    Version of Record online : 13 AUG 2008, DOI: 10.1002/pds.1631

  18. A clinicotherapeutic analysis of Stevens–Johnson syndrome and toxic epidermal necrolysis with an emphasis on the predictive value and accuracy of SCORe of Toxic Epidermal Necrolysis

    International Journal of Dermatology

    Volume 54, Issue 1, January 2015, Pages: e18–e26, Shuchi Bansal, Vijay K. Garg, Kabir Sardana and Rashmi Sarkar

    Version of Record online : 22 DEC 2014, DOI: 10.1111/ijd.12466

  19. Pharmacogenetic screening to prevent carbamazepine-induced toxic epidermal necrolysis and Stevens–Johnson syndrome: a critical appraisal

    British Journal of Dermatology

    Volume 166, Issue 1, January 2012, Pages: 7–11, K. Wu and N.J. Reynolds

    Version of Record online : 27 DEC 2011, DOI: 10.1111/j.1365-2133.2011.10754.x

  20. Distinguishing between erythema multiforme major and Stevens–Johnson syndrome/toxic epidermal necrolysis immunopathologically

    The Journal of Dermatology

    Volume 39, Issue 9, September 2012, Pages: 781–786, Shinsaku IWAI, Hirohiko SUEKI, Hideaki WATANABE, Yosuke SASAKI, Takao SUZUKI and Masafumi IIJIMA

    Version of Record online : 28 MAR 2012, DOI: 10.1111/j.1346-8138.2012.01532.x